Five computational developability guidelines for therapeutic antibody profiling
Therapeutic mAbs must not only bind to their target but must also be free from “developability issues” such as poor stability or high levels of aggregation. While small-molecule drug discovery benefits from Lipinski’s rule of five to guide the selection of molecules with appropriate biophysical prop...
Autors principals: | Raybould, MIJ, Marks, C, Krawczyk, K, Taddese, B, Nowak, J, Lewis, AP, Bujotzek, A, Shi, J, Deane, C |
---|---|
Format: | Journal article |
Publicat: |
National Academy of Sciences
2019
|
Ítems similars
-
Thera-SAbDab: the Therapeutic Structural Antibody Database
per: Raybould, MIJ, et al.
Publicat: (2019) -
Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodies
per: Robinson, SA, et al.
Publicat: (2021) -
Public Baseline and shared response structures support the theory of antibody repertoire functional commonality
per: Raybould, MIJ, et al.
Publicat: (2021) -
Computationally profiling peptide: MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies
per: Raybould, MIJ, et al.
Publicat: (2023) -
Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling
per: Raybould, MIJ, et al.
Publicat: (2024)